Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns by enabling the mass production of patient stem cells. Its proprietary technology provides a breakthrough method to grow primary stem cells in a 3D environment while maintaining stem cell characteristics of the cell